46. Psilocybin for Major Depressive Disorder | Guest Podcast

Think Neuro

Contenido proporcionado por Pacific Neuroscience Institute and Think Neuro. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Pacific Neuroscience Institute and Think Neuro o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

12M ago 29:39

MP3•Episodio en casa

In a study published on August 31, 2023, in the Journal of the American Medical Association, psilocybin showed promise as a treatment for major depressive disorder (MDD).

JAMA Associate Editor Dr. Donald C. Goff, speaks with publication author Dr. Charles L. Raison, from the Usona Institute, about the study, as well as Dr. Rachel Yehuda from Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies.

Pacific Neuroscience Institute's director of Treatment & Research In Psychedelics Center, Dr. Keith Heinzerling and PNI director Dr. Daniel Kelly were a co-investigators in this study.

221 episodios

#Science #Fitness #Biology #Medicine #Mental Health #Pacific Neuroscience Institute #Think Neuro #Neurology #Neuroscience